IQVIAIQVEarnings & Financial Report
IQVIA Holdings, Inc., headquartered in Durham, North Carolina, is an American company focused on health information technology and clinical research.
IQV Q4 2025 Key Financial Metrics
Revenue
$4.4B
Gross Profit
N/A
Operating Profit
$627.0M
Net Profit
$514.0M
Gross Margin
N/A
Operating Margin
14.4%
Net Margin
11.8%
YoY Growth
10.3%
EPS
$2.97
Financial Flow
IQVIA Q4 2025 Financial Summary
IQVIA reported revenue of $4.4B for Q4 2025, with a net profit of $514.0M (11.8% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $4.4B |
|---|---|
| Net Profit | $514.0M |
| Gross Margin | N/A |
| Operating Margin | 14.4% |
| Report Period | Q4 2025 |
IQVIA Annual Revenue by Year
IQVIA annual revenue history includes year-by-year totals (for example, 2025 revenue was $16.3B).
| Year | Annual Revenue |
|---|---|
| 2025 | $16.3B |
| 2024 | $15.4B |
| 2023 | $15.0B |
| 2022 | $14.4B |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.74B | $3.81B | $3.90B | $3.96B | $3.83B | $4.02B | $4.10B | $4.36B |
| YoY Growth | 2.3% | 2.3% | 4.3% | 2.3% | 2.5% | 5.3% | 5.2% | 10.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $26.57B | $26.40B | $27.18B | $26.90B | $27.32B | $28.63B | $28.73B | $29.94B |
| Liabilities | $20.23B | $19.68B | $20.21B | $20.83B | $21.34B | $22.85B | $22.44B | $23.31B |
| Equity | $6.34B | $6.71B | $6.97B | $6.07B | $5.98B | $5.78B | $6.16B | $6.50B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $522.0M | $588.0M | $721.0M | $885.0M | $568.0M | $443.0M | $908.0M | $735.0M |
Other Health Care Companies
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
TECH
Bio-Techne
Revenue
$295.9M
Net Profit
$38.0M
CRL
Charles River Laboratories
Revenue
$994.2M
Net Profit
$-276.6M
DHR
Danaher Corporation
Revenue
$6.1B
Net Profit
$908.0M
MTD
Mettler Toledo
Revenue
$1.1B
Net Profit
$285.8M
TMO
Thermo Fisher Scientific
Revenue
$11.1B
Net Profit
$1.6B
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B